title: Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
abstract: von Hippel-Lindau (VHL) disease is a hereditary autosomal dominant disorder associated with deletions or mutations in the VHL tumor suppressor gene. Characteristically, up to 60 % of neuroendocrine tumors (NETs) associated with VHL disease display a spectrum of clear cell morphology including multivacuolated lipid-rich cell change. Unlike neurofibromatosis type 1 and multiple endocrine neoplasia type 1 syndromes, ampullary NETs have not been described in association with VHL disease. In this report, we discuss the features of an incidental ampullary clear cell NET occurring in a patient with pancreatic VHL disease including multiple pancreatic NETs. The ampullary lesion consisted of epithelial cells resembling lipoblasts or signet ring cells. In our case, all NETs showing clear cell change were positive for inhibin. While the underlying mechanism of this finding is largely unknown, it is of note that positivity for inhibin has not been observed in clear cell NETs associated with multiple endocrine neoplasia type 1 syndrome. Our case proves that NETs can develop in the ampullary region in patients with VHL; clear cell change can occur in these lesions and can mimic signet ring cell carcinoma. This issue is of clinical significance especially in small biopsy samples; thus, positivity for keratin alone should not be taken as evidence of an adenocarcinoma. Moreover, demonstration of inhibin expression in a NET with clear cell change along with other clinical stigmata should alert the diagnostician to the possibility of VHL disease. However, further larger series examining inhibin expression in both syndrome-related and sporadic clear cell NETs are needed to confirm our findings.
authors.affiliation: Department of Pathology, University Health Network, 200 Elizabeth Street, 11th floor, Toronto, Ontario,, M5G 2C4, Canada.
authors.forename: Hasan
authors.initials: H
authors.lastname: Gucer
authors.forename: Eva
authors.initials: E
authors.lastname: Szentgyorgyi
authors.forename: Shereen
authors.initials: S
authors.lastname: Ezzat
authors.forename: Sylvia L
authors.initials: SL
authors.lastname: Asa
authors.forename: Ozgur
authors.initials: O
authors.lastname: Mete
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000150:complications / Q000378:metabolism / Q000473:pathology; D014670:Ampulla of Vater / Q000378:metabolism* / Q000473:pathology; D003138:Common Bile Duct Neoplasms / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007265:Inhibins / Q000096:biosynthesis*; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000150:complications / Q000473:pathology; D006623:von Hippel-Lindau Disease / Q000150:complications* / Q000473:pathology
chemical_list: D007265:Inhibins
references.citation: J Mol Endocrinol. 2012 Jan 25;48(1):49-60
references.pmid: 22082494
references.citation: Biochem J. 2012 Jan 15;441(2):675-83
references.pmid: 21970364
references.citation: Am J Surg Pathol. 2006 Feb;30(2):194-200
references.pmid: 16434893
references.citation: Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):401-13
references.pmid: 20833332
references.citation: Am J Surg Pathol. 1987 Jun;11(6):480-6
references.pmid: 3592062
references.citation: Am J Surg Pathol. 2010 Mar;34(3):401-4
references.pmid: 20139759
references.citation: World J Surg Oncol. 2007 Jan 17;5:6
references.pmid: 17227590
references.citation: Pancreatology. 2009;9(1-2):182-8
references.pmid: 19077470
references.citation: Front Oncol. 2012 Feb 28;2:18
references.pmid: 22649778
references.citation: J Biol Chem. 2004 May 7;279(19):19431-40
references.pmid: 14982927
references.citation: Oncol Lett. 2012 Dec;4(6):1174-1176
references.pmid: 23205114
references.citation: World J Gastroenterol. 2008 Feb 28;14(8):1299-301
references.pmid: 18300362
references.citation: Arch Pathol Lab Med. 2010 Nov;134(11):1692-6
references.pmid: 21043824
references.citation: Am J Surg Pathol. 2001 Oct;25(10):1334-9
references.pmid: 11688471
references.citation: Arch Pathol Lab Med. 2009 Mar;133(3):423-38
references.pmid: 19260748
references.citation: Endocr Pathol. 2004 Summer;15(2):141-8
references.pmid: 15299200
references.citation: Mol Cell Endocrinol. 2005 Mar 31;232(1-2):21-6
references.pmid: 15737465
references.citation: Pathology. 2013 Apr;45(3):316-30
references.pmid: 23478233
references.citation: J Cell Sci. 2012 Jul 15;125(Pt 14):3485-93
references.pmid: 22467849
references.citation: Mod Pathol. 2011 Apr;24 Suppl 2:S66-77
references.pmid: 21455203
references.citation: Endocr Pathol. 2012 Dec;23(4):243-6
references.pmid: 22923265
references.citation: Arch Pathol Lab Med. 2003 Jun;127(6):745-7
references.pmid: 12741904
references.citation: Am J Surg Pathol. 2006 Dec;30(12):1630; author reply 1630-1
references.pmid: 17122523